Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Women only

Comparing placental diffusion in diabetic and healthy pregnant women

Official title: Characterization of Placental Diffusion in Women With Diabetes Using DW-MRI

Run by Hillel Yaffe Medical Center · NCT06992245 · Data updated 2026-11-12

This study is testing if using special MRI scans can help understand how the placenta works in pregnant women with uncontrolled diabetes compared to healthy pregnant women, to see if it affects the baby’s oxygen levels.

More Pregnancy in Diabetic trials

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment40 (estimated)
SponsorHillel Yaffe Medical Center
Government
Locations1 site (Hadera)
StatusRecruiting
StartedJuly 6, 2023
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedDecember 24, 2025
Trial IDNCT06992245 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant women diagnosed with pre-gestational or gestational diabetes.

Probably not a fit

Patients with a history of placental hypoxia disease or those in active labor may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses diffusion-weighted MRI (DW-MRI) to assess and compare placental diffusion in pregnant women with uncontrolled diabetes against healthy pregnant women. The goal is to investigate the relationship between placental diffusion and potential fetal hypoxia, which may contribute to fetal death. By identifying changes in placental diffusion, the researchers hope to uncover mechanisms behind fetal damage and develop predictive protocols for at-risk pregnancies.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and prediction of fetal risks in pregnancies complicated by diabetes.

How similar studies have gone: While the approach of using DW-MRI for placental assessment is promising, it is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnancy
* Women with GDMA (Gestational diabetes) diagnosed by OGTT after 20 weeks of pregnancy

Exclusion Criteria:

* pregnant women with placental hypoxia disease related in the past
* pregnant women with placental hypoxia disease related in the present
* non-singleton pregnancy
* women in active labor or rupture of membrane
* smoking women
* suspicion of placenta accreta

Where it's running

  • Hille Yaffe Medical Center
    Hadera, Israel
    Recruiting

Study contacts

  • Principal investigator: Rinat Gabbay-Benziv, Prof — Hillel Yaffe Medical Center
  • Study coordinator: Rinat Gabbay-Benziv, Prof
  • Email: rinatg@hymc.gov.il
  • Phone: +972-4-7744514

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.